A new rapid method to detect inhibition of Amadori product generated by delta-gluconolactone. (Q47598702)

4 February 2018

title

A new rapid method to detect inhibition of Amadori product generated by delta-gluconolactone. (English)

1 reference

4 February 2018

author name string

S Rahbar

series ordinal

1

1 reference

4 February 2018

J L Nadler

series ordinal

2

1 reference

4 February 2018

publication date

1 September 1999

1 reference

4 February 2018

published in

Clinica Chimica Acta

1 reference

4 February 2018

volume

287

1 reference

4 February 2018

page(s)

123-130

1 reference

4 February 2018

issue

1-2

1 reference

4 February 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

Hemoglobin-AGE: a circulating marker of advanced glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

Mechanisms of maturation and ageing of collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

The effect of delta-gluconolactone, an oxidised analogue of glucose, on the nonenzymatic glycation of human and rat haemoglobin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900125-4

10.1016/S0009-8981(99)00125-4

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

10509901

1 reference

4 February 2018